Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram
- 27 August 2001
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 11 (4) , 275-283
- https://doi.org/10.1016/s0924-977x(01)00101-8
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Lack of Effect of Citalopram on the Steady-State Pharmacokinetics of Carbamazepine in Healthy Male SubjectsJournal of Clinical Psychopharmacology, 2001
- Fluoxetine augmentation in citalopram non-responders: pharmacokinetic and clinical consequencesInternational Journal of Neuropsychopharmacology, 2000
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsThe Lancet, 1999
- Co-administration of citalopram and clozapineInternational Clinical Psychopharmacology, 1998
- Selective Serotonin Reuptake Inhibitors and CNS Drug InteractionsClinical Pharmacokinetics, 1997
- Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarinBritish Journal of Clinical Pharmacology, 1997
- Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???Clinical Pharmacokinetics, 1996
- CitalopramTherapeutic Drug Monitoring, 1993
- The pharmacological effect of citalopram resides in the (S)-(+)-enantiomerJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopramEuropean Journal of Clinical Pharmacology, 1985